[indene-2,5'-isoxazol]-1(3H)-one and 4'-(4-(methylsulfonyl)phenyl)-3'-(3,4,5-trimethoxyphenyl)-
4'H-spiro[indene-2,5'-isoxazol]-1(3H)-one compounds containing indanonic spiroisoxazoline
core are widely known for their antiproliferative activities and investigation of
tubulin binding modes.
Objective: To evaluate the cytotoxicity effect of Dimethoxy and Trimethoxy Indanonic Spiroisoxazolines
against HepG2 cancerous liver cell line and to perform a comparison with
other known anti-liver cancer drugs.
Methods: The evaluation of cytotoxicity of dimethoxy and trimethoxy indanonic spiroisoxazoline
compounds, Oxaliplatin, Doxorubicin, 5-fluorouracil and Cisplatin against HepG2
(hepatocellular liver carcinoma) cell line has been performed using MTT assay and analyzed
by GraphPad PRISM software (version 8.0.2).
Results: Potent cytotoxicity effects against HepG2 cell line, comparable to Cisplatin (IC50=
0.047±0.0045 µM), Oxaliplatin (IC50= 0.0051µM), Doxorubicin (IC50= 0.0014µM) and 5-
fluorouracil (IC50= 0.0089 µM), were shown by both dimethoxy (IC50= 0.059±0.012 µM)
and trimethoxy (IC50= 0.086±0.019 µM) indanonic spiroisoxazoline compounds.
Conclusion: In vitro biological evaluations revealed that dimethoxy and trimethoxy indanonic
spiroisoxazoline compounds are good candidates for the development of new anti-liver